Autologous cultured chondrocytes on porcine collagen membrane | |
---|---|
Other names | MACI |
Specialty | orthopedic |
Clinical data | |
---|---|
Trade names | Maci |
License data | |
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
DrugBank | |
UNII |
Autologous cultured chondrocytes on porcine collagen membrane (Maci) is a treatment to correct cartilage defects in the knee. [1] It is used to treat symptomatic, full-thickness cartilage defects of the knee with or without bone involvement. [2] [1] Autologous cultured chondrocytes on porcine collagen membrane is an autologous cellularized scaffold product. [1] This treatment is approved by the US Food and Drug Administration (FDA). [1] It is only administered to adults. [1] Healthy cartilage is removed from the person's own knees and a 'scaffold' is created on which the healthy tissue growths. [1] This is an autologous matrix-induced chondrogenesis procedure which prevents tissue rejection complications since the transplanted cartilage comes from the same person. [3]
Autologous cultured chondrocytes on porcine collagen membrane was approved for use in the United States in May 2019. [2]
Autologous cultured chondrocytes on porcine collagen membrane | |
---|---|
Other names | MACI |
Specialty | orthopedic |
Clinical data | |
---|---|
Trade names | Maci |
License data | |
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
DrugBank | |
UNII |
Autologous cultured chondrocytes on porcine collagen membrane (Maci) is a treatment to correct cartilage defects in the knee. [1] It is used to treat symptomatic, full-thickness cartilage defects of the knee with or without bone involvement. [2] [1] Autologous cultured chondrocytes on porcine collagen membrane is an autologous cellularized scaffold product. [1] This treatment is approved by the US Food and Drug Administration (FDA). [1] It is only administered to adults. [1] Healthy cartilage is removed from the person's own knees and a 'scaffold' is created on which the healthy tissue growths. [1] This is an autologous matrix-induced chondrogenesis procedure which prevents tissue rejection complications since the transplanted cartilage comes from the same person. [3]
Autologous cultured chondrocytes on porcine collagen membrane was approved for use in the United States in May 2019. [2]